- Home
- TIL vs TRUE Comparison
TIL vs TRUE Comparison
Compare TIL & TRUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- TRUE
- Stock Information
- Founded
- TIL 2018
- TRUE 2005
- Country
- TIL United States
- TRUE United States
- Employees
- TIL N/A
- TRUE N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- TRUE Computer Software: Programming Data Processing
- Sector
- TIL Health Care
- TRUE Technology
- Exchange
- TIL Nasdaq
- TRUE Nasdaq
- Market Cap
- TIL 177.1M
- TRUE 171.0M
- IPO Year
- TIL 2021
- TRUE 2014
- Fundamental
- Price
- TIL $27.84
- TRUE $1.87
- Analyst Decision
- TIL Buy
- TRUE Buy
- Analyst Count
- TIL 6
- TRUE 5
- Target Price
- TIL $120.50
- TRUE $3.19
- AVG Volume (30 Days)
- TIL 159.0K
- TRUE 487.6K
- Earning Date
- TIL 08-13-2025
- TRUE 08-06-2025
- Dividend Yield
- TIL N/A
- TRUE N/A
- EPS Growth
- TIL N/A
- TRUE N/A
- EPS
- TIL N/A
- TRUE N/A
- Revenue
- TIL N/A
- TRUE $184,559,000.00
- Revenue This Year
- TIL N/A
- TRUE $7.54
- Revenue Next Year
- TIL N/A
- TRUE $11.02
- P/E Ratio
- TIL N/A
- TRUE N/A
- Revenue Growth
- TIL N/A
- TRUE 11.66
- 52 Week Low
- TIL $9.90
- TRUE $1.05
- 52 Week High
- TIL $92.00
- TRUE $4.62
- Technical
- Relative Strength Index (RSI)
- TIL 52.43
- TRUE 49.27
- Support Level
- TIL $25.79
- TRUE $1.88
- Resistance Level
- TIL $29.67
- TRUE $2.29
- Average True Range (ATR)
- TIL 2.62
- TRUE 0.18
- MACD
- TIL 0.10
- TRUE -0.01
- Stochastic Oscillator
- TIL 70.92
- TRUE 45.03
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About TRUE TrueCar Inc.
TrueCar Inc is a data-driven online platform operating on common technology infrastructure, powered by proprietary data and analytics. It also customizes and operates its platform for affinity group marketing partners, including financial institutions like PenFed and American Express; membership-based organizations like Consumer Reports, AARP, Sam's Club, and AAA; and employee buying programs for large enterprises such as IBM and Walmart. The Company has one operating segment, with three distinct service offerings: Dealer products and services, OEM incentives, and other.